Equity Profile

ICUI

ICU Medical, Inc.

Health CareHealth Care Supplies$3.4B

May7Thu

Post-Earnings Recap

ReportedQ1-2026After Close4:05 PM EDT

ICU Medical Beats on EPS, Stock Up 2.91%

Metric	Actual	Expected	Surprise
EPS	$1.97	$1.75	+48.12%
Revenue	N/A	$531M	N/A

management commentary, guidance changes, and full analysis available with Pro.

ICU Medical Beats on EPS, Stock Up 2.91%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$1.97	$1.75	+48.12%
Revenue	N/A	$531M	N/A

Management Commentary

Tone: Unknown

No transcript is on record for the earnings call, so the analysis is based solely on numerical results.

What It Means

ICU Medical reported better-than-expected earnings per share, which contributed to a positive stock reaction, rising by 2.91%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. The strong EPS surprise indicates potential operational strength, but the lack of revenue data means investors should remain cautious.

Company Snapshot

ICU Medical, Inc. is a healthcare company focused on developing and manufacturing innovative medical devices, particularly in the area of infusion therapy....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$1.75

Revenue

Revenue growth is vital for assessing the company's ability to expand and capture market share in the healthcare sector.

$531M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

ICU Medical, Inc. is a healthcare company focused on developing and manufacturing innovative medical devices, particularly in the area of infusion therapy. With a market cap of $3 billion, it plays a crucial role in providing essential healthcare supplies that improve patient care and safety.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q4 2025, ICU Medical reported an EPS of $1.91, significantly exceeding expectations. However, the stock experienced a slight decline of 1.25% the following day.

Management Promises & Guidance

Continued focus on innovation in infusion therapy products.
Commitment to improving operational efficiency.
Plans to expand market presence in key regions.

Expectations

Wall Street Expectations

Analysts expect ICU Medical to report strong earnings, continuing its trend of beating estimates. The consensus EPS is set at $1.75, reflecting optimism about the company's growth.

Bull Case

If ICU Medical exceeds the EPS estimate, it could reinforce investor confidence and lead to a positive stock reaction, especially given its history of surprises.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth trajectory and impact the stock negatively.

Key Metrics to Watch

EPS

$1.75

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$531M

Revenue growth is vital for assessing the company's ability to expand and capture market share in the healthcare sector.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.75?

A beat on EPS would continue the trend of strong performance and could lead to a positive market reaction.

What guidance will management provide regarding revenue growth?

Investors will closely watch for any indications of future growth, especially in light of recent strong earnings.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate ICU Medical's ability to maintain its growth trajectory, especially given its recent strong performance.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

Recent performance trends in the healthcare sector may not fully reflect ICU Medical's unique position and growth potential.

Key Risk

If revenue growth falls short of $516M, it could challenge the optimistic outlook and lead to a reevaluation of the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized as it follows a series of strong earnings surprises, setting high expectations.

Bull Confirmed If

An EPS of $1.80 or higher would confirm the bullish outlook and suggest strong operational performance.

Bear Confirmed If

An EPS below $1.66 could signal potential issues in meeting growth expectations.

Pre-Earnings Positioning

Options Market

Implied Move

±9.91%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±8.9% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

34.7%

Calls (200)P/C Ratio: 0.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations, history suggests the stock could rise by about 0.7%, confirming ongoing growth momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors digest the news.

Miss

A miss on earnings could lead to a decline, with historical data suggesting a potential drop similar to past reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in infusion therapy.
2Management's commentary on market expansion efforts.
3Insights into operational efficiencies and cost management.
4Future revenue guidance and expectations for the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

BMRNReported

BioMarin Pharmaceutical Inc.

RecapView

May4

PLTRReported

Company Snapshot

ICU Medical, Inc. is a healthcare company focused on developing and manufacturing innovative medical devices, particularly in the area of infusion therapy....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

$1.75

Revenue

Revenue growth is vital for assessing the company's ability to expand and capture market share in the healthcare sector.

$531M

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+86.10%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q4 2025, ICU Medical reported an EPS of $1.91, significantly exceeding expectations. However, the stock experienced a slight decline of 1.25% the following day.

Management Promises & Guidance

Continued focus on innovation in infusion therapy products.
Commitment to improving operational efficiency.
Plans to expand market presence in key regions.

Expectations

Wall Street Expectations

Analysts expect ICU Medical to report strong earnings, continuing its trend of beating estimates. The consensus EPS is set at $1.75, reflecting optimism about the company's growth.

Bull Case

If ICU Medical exceeds the EPS estimate, it could reinforce investor confidence and lead to a positive stock reaction, especially given its history of surprises.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth trajectory and impact the stock negatively.

Key Metrics to Watch

EPS

$1.75

Earnings per share is a key indicator of profitability and helps investors gauge the company's financial health.

Revenue

$531M

Revenue growth is vital for assessing the company's ability to expand and capture market share in the healthcare sector.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.75?

A beat on EPS would continue the trend of strong performance and could lead to a positive market reaction.

What guidance will management provide regarding revenue growth?

Investors will closely watch for any indications of future growth, especially in light of recent strong earnings.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate ICU Medical's ability to maintain its growth trajectory, especially given its recent strong performance.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a larger move than historical averages, hinting at potential surprises.

Recent performance trends in the healthcare sector may not fully reflect ICU Medical's unique position and growth potential.

Key Risk

If revenue growth falls short of $516M, it could challenge the optimistic outlook and lead to a reevaluation of the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized as it follows a series of strong earnings surprises, setting high expectations.

Bull Confirmed If

An EPS of $1.80 or higher would confirm the bullish outlook and suggest strong operational performance.

Bear Confirmed If

An EPS below $1.66 could signal potential issues in meeting growth expectations.

Pre-Earnings Positioning

Options Market

Implied Move

±9.91%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±8.9% while ICUI has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

34.7%

Calls (200)P/C Ratio: 0.00Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If ICU Medical beats expectations, history suggests the stock could rise by about 0.7%, confirming ongoing growth momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors digest the news.

Miss

A miss on earnings could lead to a decline, with historical data suggesting a potential drop similar to past reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in infusion therapy.
2Management's commentary on market expansion efforts.
3Insights into operational efficiencies and cost management.
4Future revenue guidance and expectations for the upcoming quarters.